Clinical value Target ophthalmology clinics and surgical centers with ArcScan Insight 100 to support accurate ICL sizing, improved pathology detection behind the iris, and keratoconus monitoring, positioning the device as essential for safer and more predictable anterior segment surgeries.

Small team advantage Leverage ArcScan’s lean operation to offer personalized onboarding and rapid support to independent eye clinics and specialty practices, highlighting a high-touch customer experience as a differentiator from larger competitors.

Regulatory momentum Capitalise on FDA 510(k) clearance history to reassure prospects of regulatory viability and safety, using milestones like the 2016 clearance to build credibility in conversations with procurement and clinical leads.

Strategic partnerships Explore collaborations with ophthalmic education networks and high-volume surgical centers (mirroring Cedars/Aspens engagement) to drive trials, case studies, and advocacy that accelerate adoption among surgeons and training programs.

Growth signals Emphasize the device’s scalability for clinics pursuing advanced corneal procedures and imaging insights, aligning with mid-market ophthalmology groups and showing potential for expanded use across related specialties as revenue grows toward multi-device deployments.